Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

Full results from the SURPASS trials on the drug tirzepatide shows that this new medication dramatically lowers A1C and weight and is incredibly effective in people with...
We’ve reviewed the latest research to weigh the benefits and drawbacks of intermittent fasting and time-restricted feeding for people with diabetes.
The discovery of insulin promised a new age for an ancient condition but introduced unexpected challenges. James S. Hirsch explores the riveting history of this miracle...
Wegovy, a once-weekly injectable medication (semaglutide), has been approved by the FDA to treat obesity and excess weight – conditions that can lead to type 2 diabetes...
New results show that Vida Health’s digital diabetes coaching program led to meaningful reductions in A1C levels among people with type 2 diabetes, especially for those...
From automated insulin delivery to therapeutic advances to glucose management during COVID-19, read our full coverage of one of the biggest international virtual...
The diaTribe team covers the latest in diabetes technology from the 14th annual ATTD 2021 international conference (set virtually this year). Here are our top highlights...
Two studies recently published on the Control-IQ and MiniMed 780G systems show that closed-loop automated insulin delivery significantly improves Time in Range.
Now that all adults in the US are eligible to receive a COVID-19 vaccine, we encourage everyone, especially people with diabetes or obesity, to get the vaccine as soon...
New results on Eylea, a treatment for diabetes-related retinopathy, show that the therapy reduces the risk of more serious eye complications when used for prevention.
How do our brains and bodies motivate us to eat? What makes us eat past the point of hunger? And how we can develop healthier eating habits?
Emerging evidence shows that variability in your A1C level may put you at a higher risk of stroke and heart disease.
Diabetes increases the risk of severe COVID-19 illness, but does the relationship between diabetes and the virus go in the other direction? Scientists are now studying...
Insulet’s Omnipod 5 automated insulin delivery system was shown to be effective, safe, and easy to use for adults, teens, and children with type 1 diabetes. Early...
GMI provides an estimated A1C level based on continuous glucose monitoring data and can avoid some of the limitations of A1C tests. A recent study compared actual A1C...
Vertex's new cell therapy, made from stem cells, aims to replace insulin-producing cells in people with type 1 diabetes. The therapy will soon begin testing in clinical...
To mark the hundredth anniversary of the discovery of insulin, the University of Toronto is hosting a series of presentations and seminars on the latest advances in...
At the ADA Postgraduate 2021 virtual conference, Dr. Samuel Dagogo-Jack discussed how intensive lifestyle changes can lead to prediabetes remission and prevent...
Drug company Lilly released important results showing that the new therapy may be extremely effective for people with type 2 diabetes. Across three clinical trials,...
The RADIANT study aims to define unusual forms of diabetes, to help diagnose and treat these conditions. RADIANT is recruiting people who have been diagnosed with...

Pages